CLMTBasic Materials · Specialty ChemicalsThe 6 Wall Street analysts covering Calumet, Inc. hold a median 12-month price target of $38 — -10.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 67 of 100 as at 1 Aug 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Calumet, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (99): The shares have been drifting up relative to others.
Value (16): The shares cost a lot relative to the profits and assets behind them.
The rank is the raw material. Whether the rules would actually own Calumet, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on CLMT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits −10.3% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 30 July 2026 | Goldman Sachs | Maintains | Neutral | $36 → $40 |
| 30 Mar 2026 | HC Wainwright & Co. | Maintains | Buy | $33 → $60 |
| 30 Mar 2026 | HC Wainwright & Co. | Maintains | Buy | — |
| 12 Mar 2026 | Goldman Sachs | Maintains | Buy | — |
| 30 Jan 2026 | Goldman Sachs | Maintains | Buy | — |
| 10 Nov 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 22 Oct 2025 | Goldman Sachs | Maintains | Buy | — |
| 12 Aug 2025 | UBS | Maintains | Neutral | — |
| 14 May 2025 | Wells Fargo | Maintains | Overweight | — |
| 13 May 2025 | B of A Securities | Initiates | Buy | — |
| 30 Apr 2025 | Goldman Sachs | Maintains | Buy | — |
| 9 Apr 2025 | Wells Fargo | Maintains | Overweight | — |
| 17 Mar 2025 | UBS | Upgrade | Neutral | — |
| 5 Mar 2025 | Wells Fargo | Maintains | Overweight | — |
| 3 Mar 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 12 Feb 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 4 Feb 2025 | UBS | Downgrade | Sell | — |
| 13 Jan 2025 | HC Wainwright & Co. | Maintains | Buy | — |
| 11 Nov 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 11 Nov 2024 | TD Cowen | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 30% of US stocks
Cheaper than 71% of US stocks
Cheaper than 96% of US stocks
Cheaper than 2% of US stocks
Higher than 38% of US stocks
Higher than 41% of US stocks
Higher than 4% of US stocks
Higher than 21% of US stocks
Higher than 24% of US stocks
Higher than 57% of US stocks
Higher than 37% of US stocks
Higher than 86% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CLMT appears on the weeks it earns a place.
Zacks Investment Research named Calumet, Inc. (CLMT) as one of four energy stocks that could deliver better-than-expected Q2 earnings.
Why it matters — The article flags CLMT as having potential for an earnings surprise, which could influence investor expectations heading into the Q2 reporting period.
A Zacks Investment Research article compares the year-to-date performance of Calumet, Inc. (CLMT) and Kosmos Energy (KOS) relative to their oils-energy sector.
Why it matters — A CLMT watcher would care about how the stock's performance stacks up against both a direct peer and the broader sector it belongs to.
The 6 Wall Street analysts covering Calumet, Inc. have a median 12-month price target of $38, with estimates ranging from $26 to $60. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 6 analysts covering Calumet, Inc., 2 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Calumet, Inc. 67 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, Calumet, Inc. ranks 67 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (99 of 100).
No one can know that. What the data says: the median 12-month target from 6 analysts implies -10.3% from the last close, and Ticker Nerd's factor model ranks Calumet, Inc. 67 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Calumet, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CLMT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $26 to $60 over the next 12 months.
Calumet, Inc. returned +173.2% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Calumet, Inc. is a leading manufacturer, formulator, and marketer of a diversified portfolio of specialty branded products serving consumer-facing and industrial markets across North America.
The most recent item we track (Zacks Investment Research, 30 July 2026): "4 Energy Stocks That Could Surpass Q2 Earnings Estimates". Zacks Investment Research named Calumet, Inc. (CLMT) as one of four energy stocks that could deliver better-than-expected Q2 earnings.
Calumet, Inc. is a leading manufacturer, formulator, and marketer of a diversified portfolio of specialty branded products serving consumer-facing and industrial markets across North America. The company operates through key divisions including Specialty Products and Solutions, Performance Brands, and Montana Renewables. Specialty Products and Solutions produces high-quality specialty oils such as DRAKEOL, HYPERTECH, PAROL, and PENPURE; base oils like CALICE, CALPAR, and CALVIS; solvents including CALSIA, CALTANE, and DRAKESOL; waxes under CALUMET WAX and TitanWax; and esters. The Performance Brands division focuses on premium finished lubricants, chemicals, and engineered fuels, featuring renowned brands like BEL-RAY, ROYAL PURPLE, and TRUFUEL. Montana Renewables specializes in producing sustainable aviation fuel, contributing to the renewable energy sector with clean and reliable solutions. Calumet, Inc. plays a vital role in the oil and gas refining and marketing industry, particularly in petroleum refining, by delivering innovative products tailored to customer needs in energy, transportation, and manufacturing sectors. Incorporated in 1919 and headquartered in Indianapolis, Indiana, the company emphasizes partnerships to provide customized solutions for complex industrial challenges.
CEO Mr. Louis Todd Borgmann · 1,540 employees · United States · https://www.calumet.com